KalVista Pharmaceuticals, Inc. Made Headway
Wed, Apr 29, 2026 at 07:37 PM
KalVista Pharmaceuticals, Inc. (KALV:NASDAQ) jumped higher at $26.67, a gain of 38.6%. On Wed, Apr 29, 2026, KALV:NASDAQ hit a New 2-Week High of $26.67. The stock appeared on our News Catalysts scanner on Wed, Apr 29, 2026 at 06:25 PM in the 'ACQUISITION' category. From Wed, Apr 15, 2026, the stock recorded 60.00% Up Days and 36.36% Green Days
About KalVista Pharmaceuticals, Inc. (KALV:NASDAQ)
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
Top 10 Gainers:
- Rising Dragon Acquisition Corp. (RDAC:NASDAQ), 318.57%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 84.67%
- Borealis Foods Inc. (BRLS:NASDAQ), 67.26%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 54.11%
- Inno Holdings Inc. (INHD:NASDAQ), 50%
- Akanda Corp. (AKAN:NASDAQ), 48.6%
- Silicon Motion Technology Corporation (SIMO:NASDAQ), 45.8%
- Republic Power Group Ltd (RPGL:NASDAQ), 43%
- KalVista Pharmaceuticals, Inc. (KALV:NASDAQ), 38.62%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.22%